Axxam
Axxam is an innovative Contract Research Organization (CRO) specializing in early-stage drug discovery services across the life sciences industry. Founded in 2001 and headquartered in Milan, Italy, with additional labs near Naples and a US subsidiary in Cambridge, Axxam offers integrated discovery solutions from target validation to hit and lead identification. Their services include advanced in vitro assays, high-throughput screening, and proprietary compound collections, leveraging cutting-edge technologies such as organellar electrophysiology, iPSC-derived models, optogenetics, and artificial intelligence for target identification and compound design. Beyond pharmaceuticals and biotechnology, Axxam also develops bioactive compounds for agrochemicals, food & beverage, flavors & fragrances, pet food, cosmetics, and perfume industries through their AXXSense platform. The company emphasizes scientific excellence, innovation, and quality, supporting pharmaceutical, biotech companies, start-ups, patient foundations, and academic groups globally.
Axxam
Axxam is an innovative Contract Research Organization (CRO) specializing in early-stage drug discovery services across the life sciences industry. Founded in 2001 and headquartered in Milan, Italy, with additional labs near Naples and a US subsidiary in Cambridge, Axxam offers integrated discovery solutions from target validation to hit and lead identification. Their services include advanced in vitro assays, high-throughput screening, and proprietary compound collections, leveraging cutting-edge technologies such as organellar electrophysiology, iPSC-derived models, optogenetics, and artificial intelligence for target identification and compound design. Beyond pharmaceuticals and biotechnology, Axxam also develops bioactive compounds for agrochemicals, food & beverage, flavors & fragrances, pet food, cosmetics, and perfume industries through their AXXSense platform. The company emphasizes scientific excellence, innovation, and quality, supporting pharmaceutical, biotech companies, start-ups, patient foundations, and academic groups globally.